Compare TCPC & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCPC | SIBN |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 449.7M | 886.9M |
| IPO Year | 2012 | 2018 |
| Metric | TCPC | SIBN |
|---|---|---|
| Price | $5.79 | $17.02 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $6.50 | ★ $25.57 |
| AVG Volume (30 Days) | ★ 936.0K | 561.7K |
| Earning Date | 02-26-2026 | 02-23-2026 |
| Dividend Yield | ★ 19.34% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $219,119,058.00 | $193,578,000.00 |
| Revenue This Year | N/A | $21.54 |
| Revenue Next Year | N/A | $15.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 23.27 |
| 52 Week Low | $5.29 | $12.50 |
| 52 Week High | $9.48 | $21.89 |
| Indicator | TCPC | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 56.62 | 33.61 |
| Support Level | $5.54 | $17.01 |
| Resistance Level | $5.90 | $21.89 |
| Average True Range (ATR) | 0.14 | 0.92 |
| MACD | 0.05 | -0.45 |
| Stochastic Oscillator | 80.70 | 4.08 |
BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.